Chenguang Biotech Group (300138): Significant improvement in profit margins driven by production advantages.

On April 25, 2025, Chenguang Biotech Group released the first quarter report for 2025. Total revenue in Q1 2025 was 1.716 billion yuan (a decrease of 1% year-on-year), with a net income attributable to the parent company of 0.109 billion yuan (an increase of 184% year-on-year), excluding non-recurring items.

Huaxin SecuritiesMay 8 00:00

Chenguang Biotech, Unit Obtain Eight Patent Certificates

MT NewswiresMay 6 16:43

Chenguang Biology: Report for the first quarter of 2025

SZSIApr 26 00:00 · Announcements

Express News | Chenguang Biotech Group: In the first quarter of 2025, the net income was 0.109 billion yuan, a year-on-year increase of 183.69%.

BreakingsApr 25 16:54

Chenguang Biotech Group (300138.SZ): Cottonseed protein products are high-quality protein Fodder raw materials that can be used in pet Fodder.

On April 25, Gelonghui reported that Chenguang Biotech Group (300138.SZ) stated on the investor interactive platform that the company's cottonseed protein products are high-quality protein fodder ingredients that can be applied in pet fodder.

Gelonghui FinanceApr 25 15:21

Chenguang Biotech Group (300138.SZ): The main manufacturers of its products are concentrated in China and India.

Gelonghui April 22丨Chenguang Biotech Group (300138.SZ) stated on the investor interaction platform that the production manufacturers of the company's main products are concentrated in China and India, while the share of counterparts in the USA is relatively small.

Gelonghui FinanceApr 22 15:03